1
|
Duval J, Zaanan A. [Tislelizumab in second line treatment for advanced oesophageal squamous cell carcinoma after previous treatment with platinum-based therapy]. Bull Cancer 2024:S0007-4551(24)00132-2. [PMID: 38772846 DOI: 10.1016/j.bulcan.2024.03.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/23/2024] [Accepted: 03/16/2024] [Indexed: 05/23/2024]
Affiliation(s)
- Jeanne Duval
- Département d'oncologie digestive, hôpital Saint-Antoine, université Paris Sorbonne, 184, rue du Faubourg-Saint-Antoine, 75012 Paris, France.
| | - Aziz Zaanan
- Department of Digestive Oncology, Georges-Pompidou European Hospital, Assistance publique-Hôpitaux de Paris, université Paris Cité, 20, rue Leblanc, 75015 Paris cedex, France.
| |
Collapse
|
2
|
Huguet F, Riou O, Pasquier D, Modesto A, Quéro L, Michalet M, Bordron A, Schipman B, Orthuon A, Lisbona A, Vendrely V, Jaksic N. Radiation therapy of the primary tumour and/or metastases of digestive metastatic cancers. Cancer Radiother 2024; 28:66-74. [PMID: 37806823 DOI: 10.1016/j.canrad.2023.04.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/09/2023] [Revised: 03/27/2023] [Accepted: 04/07/2023] [Indexed: 10/10/2023]
Abstract
Metastatic gastrointestinal cancer is not an uncommon situation, especially for pancreatic, gastric, and colorectal cancers. In this setting, few data are available on the impact of the treatment of the primary tumour. Oligometastatic disease is associated with longer survival in comparison with more advanced disease. Metastasis-directed therapy, such as stereotactic body radiotherapy, seems related to better outcomes, but the level of evidence is low. In most tumour locations, prospective data are very scarce and inclusion in ongoing trials is strongly recommended.
Collapse
Affiliation(s)
- F Huguet
- Service d'oncologie radiothérapie, hôpital Tenon, AP-HP, DMU Orphé, Sorbonne université, Paris, France; Laboratory of Cancer Biology and Therapeutics, centre de recherche Saint-Antoine, U938, Inserm, Paris, France.
| | - O Riou
- Institut de recherche en cancérologie de Montpellier, U1194, Inserm, université de Montpellier, Montpellier, France; Fédération universitaire d'oncologie radiothérapie d'Occitanie Méditerranée, ICM, institut régional du cancer de Montpellier, Montpellier, France
| | - D Pasquier
- Service d'oncologie radiothérapie, centre Oscar-Lambret, Lille, France; Université de Lille, CNRS, école centrale de Lille, UMR 9189 - CRIStAL, Lille, France
| | - A Modesto
- Département de radiothérapie, institut universitaire du cancer de Toulouse, Toulouse, France; Centre de recherche du cancer de Toulouse, UMR 1037, Inserm, université Toulouse-III Paul-Sabatier, Toulouse, France
| | - L Quéro
- Service de cancérologie-radiothérapie, hôpital Saint-Louis, AP-HP Nord, DMU Icare, Paris, France; Université Paris Cité, U1160, Inserm, Paris, France
| | - M Michalet
- Institut de recherche en cancérologie de Montpellier, U1194, Inserm, université de Montpellier, Montpellier, France; Fédération universitaire d'oncologie radiothérapie d'Occitanie Méditerranée, ICM, institut régional du cancer de Montpellier, Montpellier, France
| | - A Bordron
- Département de radiothérapie, centre hospitalier universitaire de Brest, Brest, France
| | - B Schipman
- Institut de cancérologie de Bourgogne, Dijon, France
| | - A Orthuon
- Institut de cancérologie de Bourgogne, Dijon, France
| | - A Lisbona
- Institut de cancérologie de l'Ouest, centre René-Gauducheau, Saint-Herblain, France
| | - V Vendrely
- Service d'oncologie radiothérapie, hôpital Haut-Lévêque, CHU de Bordeaux, Pessac, France
| | - N Jaksic
- Institut de cancérologie et radiothérapie Brétillien, Saint-Malo, France
| |
Collapse
|
3
|
Chatelain D, Moslemi A, Dreau A, Clement M. [Inflammatory bowel diseases and upper gastrointestinal tract]. Ann Pathol 2023:S0242-6498(22)00208-5. [PMID: 36822896 DOI: 10.1016/j.annpat.2022.12.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/15/2022] [Revised: 12/05/2022] [Accepted: 12/06/2022] [Indexed: 02/23/2023]
Abstract
Inflammatory bowel diseases (IBD), Crohn's disease and ulcerative colitis are inflammatory diseases with a flare-up evolution and an unknown etiology. Inflammatory lesions of the upper gastrointestinal tract are more and more often described in Crohn's disease and ulcerative colitis. The aim of this article was to review the inflammatory lesions of the esophagus, stomach and duodenum currently described in the IBD.
Collapse
Affiliation(s)
- Denis Chatelain
- Service d'anatomie pathologie CHU Amiens, Place Victor-Pauchet, 80000 Amiens, France.
| | - Amine Moslemi
- Service d'anatomie pathologie CHU Amiens, Place Victor-Pauchet, 80000 Amiens, France
| | - Axel Dreau
- Service d'anatomie pathologie CHU Amiens, Place Victor-Pauchet, 80000 Amiens, France
| | - Marine Clement
- Service d'anatomie pathologie CHU Amiens, Place Victor-Pauchet, 80000 Amiens, France
| |
Collapse
|
4
|
Xu ZC, Su BA, Li JC, Cheng WF, Chen J. Pattern of relapse following three-field lymphadenectomy of esophageal carcinoma and related factors predictive of recurrence. Cancer Radiother 2023; 27:189-195. [PMID: 36754752 DOI: 10.1016/j.canrad.2022.09.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2022] [Revised: 08/28/2022] [Accepted: 09/01/2022] [Indexed: 02/09/2023]
Abstract
PURPOSE For treatment of esophageal carcinoma, the optimal postoperative radiotherapy target volume after three-field lymph node dissection (3-FLD) had not been determined. We analyzed local recurrence pattern of thoracic esophageal carcinoma and risk factors of lymph node recurrence after 3-FLD without prophylactic radiotherapy. MATERIAL AND METHODS We reviewed 1282 patients with thoracic esophageal squamous cell carcinoma (ESCC) who were treated with 3-FLD without radiotherapy from 2010 to 2018 and analysed local recurrence patterns and risk factors of lymph node recurrence, in order to provide a reference for determination of the radiotherapy target volume for thoracic ESCC. RESULTS The lymph node recurrence accounted for 91.0% of treatment failures. The mediastinal, cervical and abdominal lymph node recurrence accounted for 84.92%, 36.07% and 22.30%, respectively (χ2=264.776, P=0.000). The superior, middle and inferior mediastinal lymph node recurrence rates were 67.54%, 27.87% and 0.98%, respectively (χ2=313.600, P=0.000). Cervical metastases were significantly associated with N stage and Preoperative cervical lymph node status. Abdominal metastases were significantly associated with the number of preoperative abdominal lymph node metastases (LNM), tumor location and N stage. CONCLUSIONS The main pattern of local-regional recurrence might be lymph node metastasis after radical 3-FLD without radiotherapy in esophageal carcinoma. The dangerous lymph node recurrence regions included neck, superior and middle mediastinum. The abdominal areas might be irradiated for lower TEC patients with preoperative abdominal LNM.
Collapse
Affiliation(s)
- Z-C Xu
- First Hospital of Quanzhou Affiliated to Fujian Medical University, 362000 Quanzhou, People's Republic of China
| | - B-A Su
- First Hospital of Quanzhou Affiliated to Fujian Medical University, 362000 Quanzhou, People's Republic of China
| | - J-C Li
- The Teaching Hospital of Fujian Medical University, Fujian Provincial Cancer Hospital, 350000 Fuzhou, People's Republic of China.
| | - W-F Cheng
- The Teaching Hospital of Fujian Medical University, Fujian Provincial Cancer Hospital, 350000 Fuzhou, People's Republic of China
| | - J Chen
- The Teaching Hospital of Fujian Medical University, Fujian Provincial Cancer Hospital, 350000 Fuzhou, People's Republic of China
| |
Collapse
|
5
|
Fekkar A, Mc Leer A, Chapuis P, Brichon PY, Chirica M, Laramas M, Valmary-Degano S. [Primary liposarcomas of the digestive tract: Diversity of clinicopathological presentations and diagnostic challenges]. Ann Pathol 2021; 41:399-404. [PMID: 34120784 DOI: 10.1016/j.annpat.2021.05.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/10/2020] [Revised: 03/21/2021] [Accepted: 05/25/2021] [Indexed: 11/21/2022]
Abstract
Sarcomas are rare tumours that represent less than 1% of all malignant tumours in adults. Liposarcomas are among the most common malignant mesenchymal tumours. They are preferentially located in the limbs and the retroperitoneum. Liposarcomas primarily arising in the digestive tract are exceptional with a few cases reported in the literature. Their clinical presentation is variable and the symptoms are not specific. Anatomopathological examination remains the gold standard for the diagnosis and the classification of these tumours, which are divided into 5 histological types according to the 5th edition of the WHO classification of soft tissue tumours. We report two observations of unusual digestive liposarcomas, located in the oesophagus and the colon, emphasizing the variability of the diagnostic challenges, depending on the clinical presentation, the histological type and the analysed material.
Collapse
|
6
|
Bendahman M, Ducloux-Lebon B, Lebon D, Fumery M, Dujardin-Boisseau A, Chatelain D. [Relevance of oesophageal biopsies during graft-versus-host disease]. Ann Pathol 2021; 41:300-309. [PMID: 33926759 DOI: 10.1016/j.annpat.2020.12.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/06/2020] [Revised: 12/12/2020] [Accepted: 12/22/2020] [Indexed: 11/29/2022]
Abstract
INTRODUCTION Graft-versus-host disease (GVHD) is a complication of hematopoietic stem cell transplantation. It frequently affects the digestive tract. Oesophageal damage is not part of its typical clinical picture. The objective of this study was to determine whether oesophageal lesions could be found in this condition. MATERIAL AND METHODS Cases coded as GVH at the CHU of Amiens in anatomopathology were identified from 2004 to 2019. Each patient who had an oesophageal biopsy was included. The slides were re-read by 2 pathologists to assess the lesions. RESULTS A total of 24 patients were included. A total of 79.1 % of the biopsies showed inflammatory lesions: 25 % erosions, 37.5 % a cleavage between the lamina propria and squamous epithelium, 41.7 % a lichenoid inflammatory infiltrate, 54.1 % apoptotic cells and 54.1 % epithelial vacuolations. 25 % of the biopsies were classified as Lerner's grade 4 (used in dermatopathology to assess cutaneous GVH lesions), 12.5 % as grade 3, 25 % as grade 2, 16.7 % as grade 1, and 20.8 % of the biopsies did not show oesophageal GVH lesions. None of the histological lesions observed were correlated with the prognosis, however erosions and epithelial cleavage were more frequently associated with death. CONCLUSION Lesions evocative and probably specific for acute GVH can be found in the esophagus. They could help and be part of the diagnosis. A protocol for oesophageal biopsy sampling, and the exclusion of other causes of esophagitis, should be performed in the future during suspicion of acute GVH.
Collapse
Affiliation(s)
- Mickael Bendahman
- Service d'anatomie pathologique-tumorothèque de Picardie, université de Picardie-Jules-Verne, CHU d'Amiens Site Nord, place Victor-Pauchet, 80000 Amiens cedex 1, France.
| | - Benjamin Ducloux-Lebon
- Service d'anatomie pathologique-tumorothèque de Picardie, université de Picardie-Jules-Verne, CHU d'Amiens Site Nord, place Victor-Pauchet, 80000 Amiens cedex 1, France
| | - Delphine Lebon
- Service d'hématologie clinique et thérapie cellulaire, université de Picardie-Jules-Verne, CHU d'Amiens Site Sud, 30, avenue de la Croix-Jourdain, 80054 Amiens cedex 1, France
| | - Mathurin Fumery
- Service d'hépato-gastro-entérologie, université de Picardie-Jules-Verne, CHU d'Amiens, CHU d'Amiens Site Sud, 30, avenue de la Croix-Jourdain, 80054 Amiens cedex 1, France
| | - Adèle Dujardin-Boisseau
- Service d'hématologie clinique et thérapie cellulaire, université de Picardie-Jules-Verne, CHU d'Amiens Site Sud, 30, avenue de la Croix-Jourdain, 80054 Amiens cedex 1, France
| | - Denis Chatelain
- Service d'anatomie pathologique-tumorothèque de Picardie, université de Picardie-Jules-Verne, CHU d'Amiens Site Nord, place Victor-Pauchet, 80000 Amiens cedex 1, France
| |
Collapse
|
7
|
Lambros L, Cholet F, Gobel Y, Le Flahec G, Schick U, Uguen A. [A rare submucosal lesion of the esophagus]. Ann Pathol 2019; 40:35-38. [PMID: 31733840 DOI: 10.1016/j.annpat.2019.10.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/02/2018] [Revised: 08/31/2019] [Accepted: 10/01/2019] [Indexed: 11/17/2022]
Affiliation(s)
- L Lambros
- Service d'anatomie et cytologie pathologiques, CHRU Brest, 29220, Brest, France
| | - F Cholet
- Service d'hépatogastroentérologie, CHRU Brest, 29220, Brest, France
| | - Y Gobel
- Service d'otorhinolaryngologie, CHRU Brest, 29220, Brest, France
| | - G Le Flahec
- Service d'anatomie et cytologie pathologiques, CHRU Brest, 29220, Brest, France
| | - U Schick
- Service de radiothérapie, CHRU Brest, 29220, Brest, France
| | - A Uguen
- Service d'anatomie et cytologie pathologiques, CHRU Brest, 29220, Brest, France.
| |
Collapse
|
8
|
Nag P, Gurjar OP, Bhandari V, Gupta KL, Bagdare P, Goyal H. Intraluminal brachytherapy boost following external beam radiotherapy with concurrent chemotherapy of oesophagus carcinoma: Results of a prospective observational study. Cancer Radiother 2018; 22:163-166. [PMID: 29615371 DOI: 10.1016/j.canrad.2017.09.008] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/24/2017] [Accepted: 09/19/2017] [Indexed: 11/26/2022]
Abstract
PURPOSE The main objective of our study is to evaluate response and toxicity profile in patients receiving external beam radiotherapy with concurrent chemotherapy followed by intraluminal brachytherapy boost for a carcinoma of the oesophagus. MATERIAL AND METHODS Twenty patients with biopsy-proven carcinoma of the oesophagus received external beam radiotherapy (50Gy in 25 fractions) with concurrent chemotherapy (cisplatin: 40mg/m2). After a gap of two to three weeks, intraluminal brachytherapy (10Gy in two fractions each 1 week apart by a high dose rate 60Co source) was given. Response was evaluated at 1 month and at 1 year of completion of treatment. In addition, acute and chronic toxicity was evaluated at 1 month and 6 months of treatment. RESULTS Complete response were seen in 80% of patients and partial response in 20% at 1 month. Moreover, there were 65% complete response, 10% local recurrences, 15% patients showed local control with distant metastasis and 10% patients died at 1 year. Grade 1, grade 2 and grade 3 oesophagitis were seen in 10%, 70% and 20% of patients respectively. Stricture was seen in 40% of patients and fistula in 10% of patients. There was no spinal cord, cardiac and nephrotoxicity found. CONCLUSIONS With the concept that high tumoricidal dose for adequate tumor control achieved by intraluminal brachytherapy as a mean of dose escalation, while sparing surrounding normal tissue and potentially improving therapeutic ratio, external beam radiotherapy followed by intraluminal brachytherapy could be a better choice for oesophagus carcinoma.
Collapse
Affiliation(s)
- P Nag
- Roentgen-SAIMS Radiation Oncology Centre, Sri Aurobindo Institute of Medical Sciences, 453555 Indore, Madhya Pradesh, India
| | - O P Gurjar
- Roentgen-SAIMS Radiation Oncology Centre, Sri Aurobindo Institute of Medical Sciences, 453555 Indore, Madhya Pradesh, India.
| | - V Bhandari
- Roentgen-SAIMS Radiation Oncology Centre, Sri Aurobindo Institute of Medical Sciences, 453555 Indore, Madhya Pradesh, India
| | - K L Gupta
- Roentgen-SAIMS Radiation Oncology Centre, Sri Aurobindo Institute of Medical Sciences, 453555 Indore, Madhya Pradesh, India
| | - P Bagdare
- Roentgen-SAIMS Radiation Oncology Centre, Sri Aurobindo Institute of Medical Sciences, 453555 Indore, Madhya Pradesh, India
| | - H Goyal
- Roentgen-SAIMS Radiation Oncology Centre, Sri Aurobindo Institute of Medical Sciences, 453555 Indore, Madhya Pradesh, India
| |
Collapse
|
9
|
Csanyi M, Arnaud M, Le Pessot F, Huet E, Piton N, Sabourin JC. [About 2 cases of ectopic sebaceous glands in esophagus: Endoscopic and histological correlations from biopsies and resected specimens]. Ann Pathol 2016; 36:134-8. [PMID: 26995103 DOI: 10.1016/j.annpat.2016.01.004] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/07/2015] [Revised: 01/21/2016] [Accepted: 01/22/2016] [Indexed: 10/22/2022]
Abstract
Sebaceous glands are cutaneous annexes located in the dermis. Focal spots of ectopy of these glands are frequently identified in ectodermal tissues: they represent Fordyce's disease. However, only a few cases of ectopic sebaceous glands have been mentioned in non-ectodermic tissue. Fordyce spots of esophageal location are unusual, and most of them have been diagnosed from biopsy specimens. We report two cases of ectopic sebaceous glands in esophagus, the first diagnosed from a resected specimen, the second from biopsies. A literature review is carried out.
Collapse
Affiliation(s)
- Marie Csanyi
- Service d'anatomie et cytologie pathologiques, hôpital Charles-Nicolle, 1, rue de Germont, 76000 Rouen, France.
| | - Maxime Arnaud
- Service d'anatomie et cytologie pathologiques, hôpital Charles-Nicolle, 1, rue de Germont, 76000 Rouen, France
| | - Florence Le Pessot
- Service d'anatomie et cytologie pathologiques, hôpital Charles-Nicolle, 1, rue de Germont, 76000 Rouen, France
| | - Emmanuel Huet
- Service de chirurgie digestive Jean-Loygue, hôpital Charles-Nicolle, 1, rue de Germont, 76000 Rouen, France
| | - Nicolas Piton
- Service d'anatomie et cytologie pathologiques, hôpital Charles-Nicolle, 1, rue de Germont, 76000 Rouen, France
| | - Jean-Christophe Sabourin
- Service d'anatomie et cytologie pathologiques, hôpital Charles-Nicolle, 1, rue de Germont, 76000 Rouen, France
| |
Collapse
|
10
|
Aubert E, Servois V. [Lymph nodes of esophagus cancer: radiological approach]. Cancer Radiother 2014; 18:553-8. [PMID: 25205427 DOI: 10.1016/j.canrad.2014.06.019] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/28/2014] [Revised: 06/20/2014] [Accepted: 06/23/2014] [Indexed: 10/24/2022]
Abstract
The cervico-thoracic-abdominal-pelvic CT-scan is a key examination of the staging of esophagus cancers. Anatomical and pathophysiological knowledge of the lymph nodes is an essential tool to establish a precise mapping. Imaging tests (such endoscopic ultrasound and PET scanning) will be very useful to determine clinical options and clinical target volume delineation for the radiotherapy of esophagus cancers.
Collapse
Affiliation(s)
- E Aubert
- Service d'imagerie médicale, institut Curie, 26, rue d'Ulm, 75005 Paris, France.
| | - V Servois
- Service d'imagerie médicale, institut Curie, 26, rue d'Ulm, 75005 Paris, France
| |
Collapse
|
11
|
Gronnier C, Mariette C. [Lymph node involvement in œsophageal cancer: surgical approach]. Cancer Radiother 2014; 18:559-64. [PMID: 25195112 DOI: 10.1016/j.canrad.2014.06.022] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/07/2014] [Revised: 06/18/2014] [Accepted: 06/21/2014] [Indexed: 11/16/2022]
Abstract
Lymph node invasion is an early event in the oesophageal carcinogenesis and represents the main prognostic factor in the curative setting. Even though the primacy of surgical resection has been challenged by the definitive radiochemotherapy for locally advanced squamous cell carcinomas of the oesophagus, surgery is now again a gold standard, in combination with (radio)chemotherapy, to improve locoregional disease control and long term survival. Surgery, especially lymphadenectomy, has consequently to be standardized through quality criteria. Lymph node stations invaded in œsophageal and junctional cancers, lymphadenectomy, and its impact on outcomes are discussed in this review based on the highest level of evidence published data.
Collapse
Affiliation(s)
- C Gronnier
- Service de chirurgie digestive et générale, hôpital Claude-Huriez, CHRU de Lille, place de Verdun, 59037 Lille cedex, France
| | - C Mariette
- Service de chirurgie digestive et générale, hôpital Claude-Huriez, CHRU de Lille, place de Verdun, 59037 Lille cedex, France.
| |
Collapse
|